MIL:PHIL

Philogen S.p.A. · MIL · Healthcare · EUR · FY for 2025

Figures on this page computed 2026-11-08 12:25 UTC

Last close

n/aEUR

Market data

3.7xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
EUR
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
73.1%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
85.3%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-08
Reported in
EUR
- computed

5 of 6 traits placed on the market's range. Nothing sits below its sector's middle.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

All from 100

lens 2 of 9

Sales

3,020

2017-12-31 to 2025-12-31100 at the start3,020

Sales: 100.00 on 2017-12-31 to 3019.74 on 2025-12-31, up 2920%.

Profit

9,187

2017-12-31 to 2025-12-31100 at the start9,187

Profit: 100.00 on 2017-12-31 to 9187.04 on 2025-12-31, up 9087%.

Shares in issue

138

2017-12-31 to 2025-12-31100 at the start138

Shares in issue: 100.00 on 2017-12-31 to 137.73 on 2025-12-31, up 38%.

Sales is at 3020, Profit is at 9187, Shares in issue is at 138, against 100 in 2017.

Sales is at 3020, Profit is at 9187, Shares in issue is at 138, against 100 in 2017.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales, where the first year is 1003,020
Source
computed
Statement
income
Fiscal year
2025
Reported in
EUR
Profit, where the first year is 1009,187
Source
computed
Statement
income
Fiscal year
2025
Reported in
EUR
Shares in issue, where the first year is 100138
Source
computed
Statement
income
Fiscal year
2025
Reported in
EUR